Suzanne Kafaja

American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis

Bevra H. Hahn, Maureen McMahon, Alan Wilkinson et al. · Arthritis Care & Research · 2012 · 1.5K citations

Medicine, Immunology, Nephrology +15

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial

Donald P. Tashkin, Michael D. Roth, Philip J. Clements et al. · The Lancet Respiratory Medicine · 2016 · 1.1K citations

Medicine, Pharmacology, Pharmacotherapy +11

Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

Dinesh Khanna, Celia J. F. Lin, Daniel E. Furst et al. · The Lancet Respiratory Medicine · 2020 · 652 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +4

Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma

Keith Sullivan, Ellen Goldmuntz, Lynette Keyes-Elstein et al. · New England Journal of Medicine · 2018 · 589 citations · Full text

Medicine, Hematology, Immunology +13

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Roy Fleischmann, Eduardo Mysler, Stephen Hall et al. · The Lancet · 2017 · 496 citations

Medicine, Pharmacology, Pharmacotherapy +12